Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to compare the efficacy of naldemedine versus placebo and to assess its effect on the time to gastrointestinal (GI) recovery following surgeries that include bowel resection and bowel transection.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Postoperative Gastrointestinal Dysfunction

NCT number NCT04355169
Study type Interventional
Source Shionogi Inc.
Contact
Status Terminated
Phase Phase 2
Start date November 6, 2020
Completion date January 4, 2021

See also
  Status Clinical Trial Phase
Completed NCT03827655 - A Study of TAK-954 to Treat Gastrointestinal Dysfunction in Adults After Surgery Phase 2